Blocking metastatic behavior of MUC16/CA-125-expressing cancer by targeting galectin-3

Authors :: E. Smith
Britta Weigelt
T. White
Thapi Dharma Rao
David R. Spriggs
E. De Stanchina
I.C. Lorenz
Noah Z. Feit
Marina Stasenko
Source :: Gynecologic Oncology. 154:46
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Oncology
business.industry
Blocking (radio)
Galectin-3
Cancer research
Obstetrics and Gynecology
Medicine
Cancer
business
medicine.disease

Full Text Access

Tools